Home/Investors/National Institutes of Health (SBIR)

National Institutes of Health (SBIR)

Biotech Investor · 2 portfolio companies

Portfolio
2
Focus Areas
1
Top Stage
Pre-clinical

Investment Focus

Portfolio Companies

CompanyValuation
MicroPure Genomics
Migra-Therapeutics